Vocalbeats.AI, a Singapore-based AI innovation company, has launched Glowise, an all-in-one companion app for individuals using GLP-1 medications. The app seeks to address a common challenge: the fragmentation of health data across multiple apps and notes. By bringing medication reminders, dose logs, food and nutrition tracking, hydration, side-effect notes, weight trends, and activity progress into one place, Glowise aims to provide a cohesive view of a user's routine. This matters because GLP-1 users often juggle several tools to manage different aspects of their treatment, leading to a disjointed record that can be hard to interpret. With Glowise, users can revisit their medication records alongside meals, protein intake, water consumption, and how they felt, potentially leading to more informed discussions with healthcare providers.
The app's design philosophy centers on reducing the effort required to maintain a useful record. Features like AI-assisted logging through VoiceLog, food photos, barcode and label scans, and menu scans offer multiple ways to capture food information without manual entry. As Marco Lai Jinnan, CEO of Vocalbeats.AI, stated, "Users are not looking for more fields to fill." The product is intended to keep medication, meals, and everyday notes close together so people can review their own routine without switching between separate trackers. This approach could encourage more consistent tracking, which is crucial for understanding the relationship between medication, diet, and side effects over time.
For those exploring GLP-1 tracking options, Glowise provides resources such as a GLP-1 tracker for the whole journey that frames medication as only one part of the routine. The company also published a guide to the best GLP-1 tracker apps for different needs in 2026, and a focused look at the best semaglutide apps for tracking your routine. These resources help users make informed decisions about which tools best suit their needs.
Glowise is available for iPhone and Android and can be accessed at glowise.app. It is important to note that the app is designed for tracking and education only and does not provide medical advice, diagnose conditions, or prescribe medications or doses. Users should consult a qualified healthcare professional for treatment decisions. The launch of Glowise reflects a growing trend of digital health tools that aim to empower patients with data while emphasizing the importance of professional medical guidance. By consolidating various tracking elements, Glowise may help users better understand their GLP-1 journey and engage more effectively with their healthcare team.
